By Michael Gwarisa Zimbabwe is among five African countries that have started administering the world’s first all-oral treatment for Trypanosoma brucei rhodesiense sleeping sickness—a rare but deadly disease that has long affected communities in East and Southern Africa. The development marks a turning point in the fight against this neglected tropical disease, especially in endemic